Pharmaceutical giant Eli Lilly said Thursday it will seek approval to add its diabetes drug to the buzzy US weight loss market after achieving promising results in a new clinical trial.
Apr 27, 2023
0
2
The U.S. biosimilar drug market emerged in 2015 to provide safe, effective, and more affordable alternatives to existing biologic drugs, but it has been slow to develop compared with Europe.
Jun 6, 2023
0
1
Cigarette makers are using synthetic menthol substitutes in what appears to be an effort to skirt a looming federal menthol ban, researchers say.
Oct 11, 2023
0
1
The French competition authority (AFC) on Thursday slapped a record 444 million euro ($500 million) fine on pharma groups Novartis, Roche and Genentech over market abuses in sales of macular degeneration drugs.
Sep 9, 2020
0
3
In a Special Communication in JAMA, "The High Cost of Prescription Drugs in the United States Origins and Prospects for Reform," Kesselheim and colleagues reviewed the peer reviewed medical and health policy literature from ...
Aug 23, 2016
0
1
(HealthDay)—In an effort to quickly develop drugs that could prevent or slow Alzheimer's, the U.S. Food and Drug Administration said it plans to relax the approval process for experimental medications for the memory-robbing ...
Mar 14, 2013
0
0
The abortion pill will become available in Japan for the first time after the health ministry approved the drug used to terminate early-stage pregnancy.
Apr 29, 2023
0
2
The tobacco industry has long appealed to youth through targeted marketing that glamorizes smoking with imagery of candy-flavored products, celebrity endorsements, social settings, and other enticing tactics. That marketing ...
Apr 23, 2024
0
1
Ashish Poddar kept an ice pack on hand as he waited outside a New Delhi hospital for a black market dealer to deliver two drugs for his father, who was gasping for breath inside with COVID-19.
Apr 29, 2021
0
0
Conflict-of-interest statements made by physicians and scientists in their medical journal articles after they had been allegedly paid by pharmaceutical manufacturers as part of off-label marketing programs are often inadequate, ...
Aug 7, 2012
0
0
